About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, June 14th, 2017

The QualityStocks
Daily Stock List


Legacy Education Alliance, Inc. (LEAI)

RedChip, Marketbeat, DSR News, PHUB News, Stock Commander, Fortune Stock Alerts, and PennyPickAlerts reported on Legacy Education Alliance, Inc. (LEAI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Legacy Education Alliance, Inc. is a foremost global provider of practical, high-quality, and value-based educational training. This training is on the topics of personal finance, entrepreneurship, real estate, and financial markets investing strategies and techniques. The Company’s dedication is to providing quality financial education.

Established in 1996, Legacy Educational Alliance has headquarters in the United States, Canada, and the United Kingdom (UK). The Company is a worldwide business and has cumulatively served greater than two million students from more than 150 nations and territories over the course of its operating history. Legacy Educational Alliance lists on the OTC Markets Group OTCQB.

It provides its training through an array of brands. These include Trade Up Investor Education™; Rich Dad® Education; Rich Dad® Stock Education; Making Money from Property with Martin Roberts™; Brick Buy Brick™; Building Wealth; Robbie Fowler Property Academy™; Women in Wealth™; The Independent Woman™; and Elite Business Star™.

The Trade Up Investor Education™ brand underwent development in partnership with Investor's Business Daily®. Students are provided educational training designed to help them build their knowledge of stock and options trading. The design of Robbie Fowler Property Academy™ is to teach investment strategies people can use to realize a clear path towards long-term wealth.

The Making Money from Property with Martin Roberts™ brand provides a property-based curriculum centered on how and why to buy property at auction. Rich Dad® Education provides students with wide-ranging instruction and mentoring in real estate and financial instruments training in the United States, Canada, and the UK. The Brick Buy Brick™ brand introduces its students to the tools and strategies employed by successful investors to become financially free via real estate investing.

The Independent Woman™ is a leader in the effort to provide educational training, seminars, and services designed to help women build their financial intelligence. The Women In Wealth™ brand seeks to empower women with a strong financial education and help them in discovering the power of real estate investing to create cash flow and build financial independence.

The design of the Elite Business Star™ brand was in partnership with Mr. Kevin Harrington, a very successful entrepreneur. The creation of Elite Business Star™ was to show an individual what it takes to be a star in their industry. The Rich Dad® Stock Education training brand assists its students in becoming astute investors who understand how to create winning trades and potential profits in any market condition.

Recently, Legacy Education Alliance announced the release of Assets Cubed. This is a new book by Mr. Anthony C. Humpage, Chief Executive Officer of the Company. Assets Cubed presents a ground-breaking new way to grow, protect, and also preserve one’s wealth through taking a broader perspective, one that crosses and incorporates all asset classes.

Legacy Education Alliance, Inc. (LEAI), closed Wednesday's trading session at $0.34, up 11.48%, on 17,322 volume with 4 trades. The average volume for the last 60 days is 20,920 and the stock's 52-week low/high is $0.14/$0.48.

Applied Minerals, Inc. (AMNL)

Wall Street Resources and Real Pennies reported previously on Applied Minerals, Inc. (AMNL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Applied Minerals, Inc., by way of its ownership of the historic Dragon Mine deposit, is the foremost international producer of Dragonite™ halloysite clay and Amiron™ advanced natural iron oxides. The Company’s products address the global need for high performance, eco-friendly solutions for a variety of industrial applications.

Its Dragonite™ is a versatile Halloysite product grade. It has a broad spectrum of applications. It is an advanced reinforcing filler. The Company launched its AMIRON line of advanced natural iron oxide pigments to the construction, wood coatings, paints, industrial coatings, plastics and rubber markets in 2014.  Listed on the OTCQB, Applied Minerals is based in New York, New York.

Halloysite is an aluminosilicate clay. It exhibits a rare, naturally occurring hollow tubular structure. Halloysite tubes have a length in the range of 0.5 - 3.0 microns, an exterior diameter in the range of 50 - 70 nanometers, and an internal diameter (lumen) in the range of 15 - 30 nanometers.

Applied Minerals serves the traditional halloysite markets for use in technical ceramics and catalytic applications. The Company is the top producer of Halloysite clay and advanced, ultra-pure natural iron oxide solutions – consisting of hematite and goethite - from its wholly-owned Dragon Mine property in the State of Utah.

Additionally, it has developed niche applications that benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints, coatings and building materials, environmental remediation, agricultural applications, and high-performance additives & fillers for plastic composites.

The Company’s Dragonite-XR™ product grade provides innovative advantages in comparison to other reinforcing fillers, such as glass fiber, mica, wollastonite or talc.

Its Dragonite-HP™ is a high-performance additive for engineering thermoplastics used at loadings of only 1-3 percent. It provides first-rate mechanical performance and cycle time reduction. Furthermore, its Dragonite-PureWhite™ is the highest purity Dragonite™ product. It meets the strict specifications of the cosmetic industry.

Pertaining to Iron Oxide products, Applied Minerals offers the above-mentioned Amiron. This is an advanced natural iron oxide for an assortment of pigmentary and technical applications.

This past April, Applied Minerals reported its financial results for Q4 and full year ended December 31, 2016. Selected financial highlights include Revenue in Q4 of 2016 of $0.9 million, versus $0.2 million in Q4 of 2015. Revenue for the full year 2016 was $4.0 million, versus $0.5 million in 2015.

Cash used in operating activities during Q4 of 2016 was $0.8 million, versus $1.9 million in Q4 of 2015. Cash used in operating activities in the full year 2016 was $2.7 million, versus $8.6 million in 2015. Applied Minerals incurred an operating loss of $1.0 million in Q4 of 2016. This represents an improvement of roughly $1.0 million versus $2.0 million in the same period in 2015.

Applied Minerals, Inc. (AMNL), closed Wednesday's trading session at $0.035, even for the day. The average volume for the last 60 days is 118,222 and the stock's 52-week low/high is $0.02/$0.19.

Where Food Comes From, Inc. (WFCF)

Marketbeat, The Bowser Report, SmallCapVoice, and Wyatt Investment Research reported beforehand on Where Food Comes From, Inc. (WFCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Where Food Comes From, Inc. (d.b.a. IMI Global, Inc.) is a trusted resource for third party verification of food production practices. The Company supports more than 10,000 farmers, ranchers, processors, retailers, distributors, and restaurants with an extensive array of value-added services via its IMI Global, International Certification Services, Validus Verification Services, and Sterling Solutions units. Listed on the OTCQB, Where Food Comes From has its corporate office in Castle Rock, Colorado.

Where Food Comes From has a solutions portfolio that covers beef, pork, poultry, lamb, dairy, eggs, and organic. Its solutions portfolio includes offerings ranging from source and age, non-hormone and humane handling to organic, non-GMO and gluten free.

The Company's Where Food Comes From® retail and restaurant labeling program uses the verification of product attributes to connect consumers to the sources of the food they buy through product labeling and web-based information sharing and education. Employing QR code technology, consumers can quickly access information concerning the producers behind their food.

The Company’s Sterling Solutions is a top provider of third-party verification services in the western United States. Sterling Solutions serves large dairies, calf ranches, as well as cattle operations. It has over 10 years of on-farm auditing experience. It operates as a wholly-owned subsidiary of Where Food Comes From.

Where Food Comes From’s Validus Verification Services is a leader in independent certification of socially responsible production practices encompassing pork, poultry, and dairy products. Validus Verification Services is a wholly-owned subsidiary of the Company.

Where Food Comes From has acquired, for cash and stock, a 60 percent interest in privately held SureHarvest, Inc. SureHarvest is a foremost provider of agri-food sustainability solutions. This transaction was valued at approximately $2.8 million. Additionally, the Company has right of first refusal on the remaining 40 percent interest in SureHarvest. SureHarvest provides a wide assortment of sustainability and farming MIS solutions, certification and compliance management, and a multitude of professional services.

In March 2017, Where Food Comes From announced that its IMI Global subsidiary was selected as the Non-GMO Project Technical Administrator for Country Natural Beef's new brand, Oregon Country Beef. Oregon Country Beef is completely Non-GMO Project Verified. Country Natural Beef is an Oregon-based, consumer-driven, beef marketing cooperative comprising100 family ranches aggregating 100,000 mother cows on millions of acres of public and private land. Its products sell in restaurants and retail locations globally.

In April, Where Food Comes From announced that Fonterra chose the Company to serve as its Non-GMO Project Technical Administrator for the North American launch of its NZMP non-GMO dairy ingredient range. Fonterra is an international dairy nutrition co-operative owned by 10,500 farming families in New Zealand. Together, they form the world's largest milk processing company.

Recently, Where Food Comes From announced it acquired privately held A Bee Organic, a USDA Accredited Certification Agency. A Bee Organic provides over 125 customers with National Organic Program (NOP) certifications for hydroponic, aquaponic, in-ground and wild crops. This includes avocados, blueberries, citrus and stone fruits, greens, and manzanita.

Where Food Comes From, Inc. (WFCF), closed Wednesday's trading session at $2.45, even for the day, on 12,002 volume with 5 trades. The average volume for the last 60 days is 9,232 and the stock's 52-week low/high is $1.83/$2.70.

Dais Analytic Corp. (DLYT)

SmallCapVoice, BullRally, CoolPennyStocks, HotOTC, MadPennyStocks, PennyInvest, PennyStockVille, StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, SmallCap Pulse, and Greenbackers reported earlier on Dais Analytic Corp. (DLYT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A commercial nanotechnology materials business, Dais Analytic Corp sells its industry-changing nanomaterial technology into the global water, air, and energy markets. The Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its unique Aqualyte™ family of nano-structured materials and processes centering on disruptive air, energy, and water applications. OTCQB-listed, Dais Analytic is headquartered in Odessa, Florida.

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product). Moreover, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle.

Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water. The NanoClear™ process has consistently shown that the Company’s novel Aqualyte® material can separate most contaminants from water, realizing almost 'parts per billion' clean product water with little or no fouling of the vital membrane component.

NanoClear™ is a leading-edge water cleaning architecture enabled by the features in Dais’ nanomaterial - Aqualyte™. The NanoClear™ product line is an essential application in purifying contaminated water having high salt content, low pH, or where the need for Total Dissolved Solid (TDS) in the product water is 10 or less.

Additionally, uses include NanoCAP™. The Company indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and 'smart grid' configurations.

Dais Analytic earlier entered into a definitive agreement with SoEX (Hong Kong) Industry & Investment Co. This agreement is to form a People’s Republic of China (PRC) company, owned by both parties, to build and sell Dais’ ConsERV™ High Efficiency Energy Recovery Ventilator (ERV) into the greater China market and select use of Dais’ Aqualyte™ nanomaterial to clean up contaminated water. SoEX Hong Kong has an established manufacturing and distribution network.

This past April, Dais Analytic announced that it entered into a three-year Cooperation Agreement with Beijing Geoenviron Engineering and Technology, Inc. (BGE), a leader in providing advanced pollution prevention and treatment solutions in Mainland China, to distribute Dais Analytics’ NanoClear™ products for the treatment of aggressively contaminated industrial wastewater.

With this Agreement, BGE will use its well-established sales organization and distribution channels to promote and sell NanoClear™ membrane evaporators to treat wastewater in the petrochemical and electric power industries in Mainland China. BGE will establish a pilot project. This project will serve as an essential part of BGE's marketing strategy for NanoClear and subsequently purchase a minimum of 16 systems during the three-year term of the Agreement. BGE will purchase membrane evaporators from Dais Analytic and design, procure, and buildout the balance of the water pollution treatment systems with Dais providing guidance and support for the NanoClear part of the systems.

Last month, Dais Analytic announced that it received an order for delivery of its first NanoClear™ product targeted to be used for the increasing market for the desalination of water. Aquabaero Environment Protection LTD is using Dais's patented NanoClear™ water purification system to provide supreme efficiency in desalination projects. This desalination project is one of three projects that Aquabaero is undertaking with NanoClear systems.

Dais Analytic Corp. (DLYT), closed Wednesday's trading session at $0.0299, up 6.79%, on 7,537 volume with 1 trade. The average volume for the last 60 days is 40,157 and the stock's 52-week low/high is $0.013/$0.20.

Spindle, Inc. (SPDL)

TopPennyStockMovers and SmallCapVoice reported earlier on Spindle, Inc. (SPDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Spindle, Inc. is a leading provider of unified commerce solutions centered on the Small and Medium-sized Business (SMB) market. The Company is an innovator of merchant and consumer-facing commerce solutions. It is focusing on pioneering new ways for businesses to speedily integrate mission critical business services, payment acceptance, and mobile marketing services. This is while empowering location-based merchant discovery, fulfillment, and frictionless consumer engagement. Spindle is based in Mesa, Arizona.

The CATALYST Marketing System components and CATALYST IP were included in the asset acquisition from Catalyst Business Development, Inc. that Spindle completed in 2015. Catalyst Business Development is a Scottsdale, Arizona-based provider of payment gateway services, sales, and software solutions.

Spindle is concentrating on payment processing services and integrating value-added capabilities, which enhance merchant revenue and increase consumer loyalty, experience, and retention. The Company’s dedication is to provide unique solutions that exceed traditional boundaries, and permit clients, partners, merchants, and consumers to take full advantage of the fast-developing mobile economy.

Spindle’s comprehensive proprietary intellectual property (IP) portfolio (which includes patents pending) covers networks, mobile payments, and security. The Company integrates acceptance channels. In addition, Spindle is pushing the boundaries through adding big data collection, analytics, marketing, loyalty and points programs and integration with other domains (including security systems and business automation products).

Spindle’s payment aggregation platform was purpose built for high volume processing and boarding. Underwriting, risk management, merchant APIs, funding and settlement are all built into a single cloud based platform. Concerning Point-Of-Sale (POS) & MPOS, Spindle has a POS solution built around the power of the cloud. This is for restaurants and retail to mobile vendors and event organizers.

Spindle acquired Yowza!! - a provider of mobile couponing technology. This technology is integrated with Spindle's platform. Spindle signed distribution agreements with a broad spectrum of channel partners. By way of these relationships, it can provide comprehensive mobile commerce services via manifold channels. These channels include wireless providers, vending services operators, as well as technology solutions providers.

Recently, Spindle announced that it finalized an agreement to acquire specific digital marketing software assets from CoverCake, Inc., specifically, CoverCake's intelligent algorithms for data mining and consumer engagement. CoverCake's software is envisaged to enhance the sophistication and proprietary strengths of Spindle's CATALYST Platform. CoverCake's software capabilities include intelligent content aggregation; data mining on different social media data feed platforms, and a strong Content Management System (CMS) backend.

Spindle also recently announced that it executed two strategic agreements with Concourse Team Express. With this strategic relationship, Team Express will use the CATALYST Team Sports Platform to offer teams the ability to manage their rosters, collect fees, integrate social media, team scheduling, statistics, location directions, and more.

CATALYST Team Sports will be adding the Team Express custom teamwear and team store solutions to the platform. This is to enable teams innovative fundraising opportunities while providing teams, players, and fans a year-round source for the latest, top-of-the-line equipment, apparel, and footwear from the most recognized sporting goods brands at very reasonable prices. Team Express is a top multi-channel internet retailer.

Spindle, Inc. (SPDL), closed Wednesday's trading session at $0.187, even for the day, on 200 volume with 1 trade. The average volume for the last 60 days is 63,636 and the stock's 52-week low/high is $0.046/$0.30.


The QualityStocks
Company Corner


ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.42, up 4.48%, on 5,545 volume with 11 trades. The stock’s average daily volume over the past 60 days is 133,956 and its 52-week low/high is $0.05/$2.09.

ORHub, Inc. today announces that it is launching its new service module for hip and knee surgical procedures, July 2017. With over 100 million surgeries performed in the U.S. every year and growing, this new service line significantly expands the addressable market for the Company's dynamic analytics capabilities and Surgical Resource Management platform. "The launch of this new module follows the successful launch of our spine module, which for the past eight months has been in continuous use in two nationally recognized hospitals, achieving overwhelming success. Our hips and knees module is the second of many on our technical road map that will allow us to exponentially grow our addressable market and take advantage of the resulting opportunities," says ORHub CEO Colt Melby.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub, Inc. Expands its Addressable Market with Launch of Transformative Hip and Knee Module

ORHub (ORHB) Enhances Leading Data Analytics Platform with Integration of Sterilization Process Module

ORHub (ORHB) Appoints New Chief Operating Officer to Facilitate Growth Strategies

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.02876, up 6.52%, on 10,919,504 volume with 430 trades. The stock’s average daily volume over the past 60 days is 4,251,058, and its 52-week low/high is $0.0062/$0.142.

CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article that will take a look at SinglePoint Inc. and its partnership with First Bitcoin Capital Corp. to bring effective payment solutions to the cannabis industry. Please follow the link to read the full article: http://www.cannabisfn.com/singlepoint-embraces-bitcoin-solve-cannabis-payments/

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint Embraces Bitcoin to Solve Cannabis Payments

NetworkNewsWire Announces Publication on the Potential of Bitcoin to Address Banking Concerns of Cannabis Industry

SinglePoint and First Bitcoin Capital Partner Up In An Effort To Solve Payment Problems in the Cannabis Industry Through Bitcoin and blockchain alternative payment technology

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.03, even for the day, on 12,899 volume with 31 trades. The stock’s average daily volume over the past 60 days is 65,102 and its 52-week low/high is $0.12/$2.75.

ChineseInvestors.com today announces that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. CBD Biotechnology Inc. will focus on research, development and distribution of health products, including hemp-derived cannabidiol ("CBD") products, as well as hemp-based food and beverage products.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

ChineseInvestors.com, Inc. Launches CBD Biotechnology Inc. in British Columbia, Canada

ChineseInvestors.com Has an Edge in Lucrative Hemp Oil Industry -- CFN Media

ChineseInvestors.com, Inc. Engages Venture Building Firm 'Launch Haus, LLC' to Drive its Hemp-based eCommerce and Network Marketing Business Divisions

InMed Pharmaceuticals, Inc. (IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.2935, off by 4.86%, on 282,619 volume with 138 trades. The stock’s average daily volume over the past 60 days is 1,051,779, and its 52-week low/high is $0.05/$0.72.

CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing InMed Pharmaceuticals Inc. and the progress it is making in advancing its lead clinical trial candidate. Please follow the link to read the full article: http://www.cannabisfn.com/inmed-pharma-advances-clinical-trials-cro-deal/

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Pharma Advances Toward Clinical Trials with CRO Deal

InMed Announces Agreement to Advance a Topical Formulation of INM-750

InMed Raises $5.75 Million Through Underwritten Financing Including Full Exercise of the Over-Allotment Option

BlastGard International Inc. (BLGA)

The QualityStocks Daily Newsletter would like to spotlight BlastGard International Inc. (BLGA). Today, BlastGard International Inc. closed trading at $0.0279, up 39.50%, on 91,767 volume with 5 trades. The stock’s average daily volume over the past 60 days is 104,180 and its 52-week low/high is $0.004/$0.03.

BlastGard International Inc. (BLGA) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

Blastguard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

BlastGard International Inc. Blog

BlastGard International Inc. News:

BlastGard International Inc. (BLGA) is “One to Watch”

BlastGard International Addresses Company's Trading Activity

Big Trading Volumes for BlastGard International Initiates Due Diligence Report


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Trader Power News
(AEMD) +50.00%


(GLOW) +42.16%


(BLGA) +39.50%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251